Results 241 to 250 of about 484,321 (343)

A case of hypertrophic cardiomyopathy presenting with high-degree atrioventricular block. [PDF]

Medicine (Baltimore)
Gu Y, Chen F, Zhang C.
europepmc   +1 more source

FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1485-1489, April 2025.
Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran, Vinay Randhawa, Usman A. Tahir, Matthew Robertson, Anam A. Waheed, Anna Perillo, Leanne Barrett, Ron Blankstein, Mark W. Feinberg, Marcelo F. Di Carli, Neal K. Lakdawala   +10 more
wiley   +1 more source

Septic cardiomyopathy phenotype in the critically ill may depend on antimicrobial resistance

Vasiliki Tsolaki, Kyriaki Parisi, George Ε. Zakynthinos, Efrosini S. Gerovasileiou, Nikitas Karavidas, Vasileios Vazgiourakis, Epaminondas Zakynthinos, Demosthènes Makris   +7 more
openalex   +1 more source

Pathological Features of Lamin Cardiomyopathy

, 2020
Hiroaki Kawano, Takashi Ishimatsu, Koichi Kawamura, Mitsuaki Ishijima, Tomayoshi Hayashi, Taisuke Ishikawa, Naomasa Makita, Koji Maemura   +7 more
openalex   +2 more sources

Multimodality imaging in hypertrophic cardiomyopathy. [PDF]

J Cardiovasc Imaging
Kim J, Lee SC.
europepmc   +1 more source

Atrial Dilated Cardiomyopathy: From Molecular Pathogenesis to Clinical Implications. [PDF]

J Clin Med
Carella MC, Dicorato MM, Santobuono VE, Dentamaro I, Basile P, Piccolo S, Labellarte A, Latorre MD, Urgesi E, Pontone G, Resta N, Arbustini E, Ciccone MM, Guaricci AI, Forleo C.   +14 more
europepmc   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias [PDF]

, 2019
Cuculich, Phillip, et al,
core   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Monomorphic Ventricular Arrhythmias in Athletes

Arrhythmia & Electrophysiology Review, 2019
Jeffrey J Hsu, Ali Nsair, Jamil A Aboulhosn, Tamara B Horwich, Ravi H Dave, Kevin M Shannon, Noel G Boyle, Kalyanam Shivkumar, Jason S Bradfield   +8 more
doaj   +1 more source